NOVO NORDISK V BIO-TECHNOLOGY, No. 04-1581 (Fed. Cir. 2005)
Annotate this Case
Download PDF
United States Court of Appeals for the Federal Circuit CORRECTED: October 5, 2005 at 1:00 PM 04-1581 NOVO NORDISK PHARMACEUTICALS, INC., and NOVO NORDISK A/S, Plaintiffs-Appellants, v. BIO-TECHNOLOGY GENERAL CORP. and TEVA PHARMACEUTICALS USA, INC., Defendants-Appellees. Steven E. Lipman, Darby & Darby, P.C., of New York, New York, argued for plaintiffs-appellants. Of counsel were James Edward Hanft, Paul M. Zagar, Jay P. Lessler, Kevin L. Reiner, Robert Schaffer and Joseph R. Robinson. John W. Bateman, Kenyon & Kenyon, of Washington, DC, argued for defendants-appellees. On the brief was Richard L. DeLucia, of New York, New York. Of counsel were Steven J. Lee, and Thomas J. Meloro, of New York, New York, and Kenneth R. Corsello, of Washington, DC. Appealed from: United States District Court for the District of Delaware . Chief Judge Sue L. Robinson
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
